KRAS and neoplasm: In KRAS mutant NSCLC, FAO is facilitated by the upregulation of long-chain acyl-CoA synthetase 3 (ACSL3), the enzyme responsible for activating free FAs, allowing tumor cells to meet the increased ATP demand [2].